Abstract: Computer graphics may be detected in digital images by extracting a first set of features from an input digital image, extracting a second set of features from a prediction-error image derived from the input digital image, and applying a classification algorithm to the first set of features and the second set of features to determine if the combined sets of features indicate that the input digital image corresponds to computer graphics.

Abstract: Methods and apparatus are provided for subjecting an original, pixel domain image to an Integer Wavelet Transform (IWT) to obtain a matrix of wavelet coefficients; selecting at least one bit plane between a least significant bit plane and a most significant bit plane of the matrix of wavelet coefficients; compressing the at least one selected bit plane to produce free space in the at least one selected bit plane; embedding hidden data in the free space of the at least one compressed bit plane; and subjecting the at least one embedded bit plane to an Inverse IWT to produce a marked pixel domain image. Methods and apparatus are also provided for reversing this process.

Abstract: Briefly, in accordance with one embodiment, a method of identifying marked content is described. For example, although claimed subject matter is not limited in this respect, in one embodiment, a class-wise non-principal components approach may be employed.

Abstract: The subject matter disclosed herein related to techniques for detecting tampering of the digital image data.

Abstract: The present invention relates to melanocortin receptor agonists of formula (I), which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction

Abstract: Briefly, embodiments of a method of identifying marked images, in which higher order statistical moments based at least in part on a JPEG array are employed, is described

Abstract: Briefly, in accordance with one embodiment, a method of identifying marked content is described.

Abstract: Briefly, in accordance with one embodiment, a method of identifying marked images based at least in part on frequency domain coefficient differences is disclosed.

Abstract: The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.

Abstract: The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction

Abstract: Briefly, embodiments of a method and system for steganalysis are disclosed.

Abstract: The present invention is directed to a compound of formula I, or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.

Abstract: Briefly, embodiments of methods and/or systems for data hiding using inter-word space modulation is disclosed.

Abstract: A coenzyme Q10 and ceramide-containing preliposome, and pharmaceutical preparations and cosmetics containing the same. The preliposome can further comprise other lipid components. A granular and lyophilized solid-preparation is produced by lyophilization or spray drying. Then, the coenzyme Q10-containing proliposome is obtained by adding water in the said solid-preparation and shaking. Transdermal absorption of coenzyme is improved together with the effect of coenzyme Q10 in cosmetics and the stability of coenzyme Q10 and liposome, which facilitate the formulation of cosmetics.

Abstract: This invention belongs to the chemical field, which is related to the fields of pharmaceutical preparations and cosmetic, especially to asiaticoside-liposome and its use for preparing pharmaceutical preparations and cosmetic. In this invention, asiaticoside and lipid components are fused by heating or dissolved in organic solvents, then treated with the rotary thin layer evaporation technique, hydrated by adding aqueous solution under shaking to afford lipid dispersing aqueous solution, and then treated by using the technics of sonication, homogeneous emulsification, microjet and extruding filtration to enwrap asiaticoside in the middle of liposomal bilayer membranes to form the hydrophilic asiaticoside-liposome.

Abstract: Methods and apparatus are provided for subjecting an original, pixel domain image to an Integer Wavelet Transform (IWT) to obtain a matrix of wavelet coefficients; selecting at least one bit plane between a least significant bit plane and a most significant bit plane of the matrix of wavelet coefficients; compressing the at least one selected bit plane to produce free space in the at least one selected bit plane; embedding hidden data in the free space of the at least one compressed bit plane; and subjecting the at least one embedded bit plane to an Inverse IWT to produce a marked pixel domain image. Methods and apparatus are also provided for reversing this process.

Abstract: A system and method are disclosed which may include subjecting an original, pixel domain image to an Integer Wavelet Transform (IWT) to obtain a first matrix of IWT coefficients; multiplying selected ones of the IWT coefficients by two; and embedding a data bit in a LSB (Least Significant Bit) position of each selected coefficient, thereby providing a marked image.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: A system and method are disclosed which may include subjecting an original, pixel domain image to an Integer Wavelet Transform (IWT) to obtain a matrix of IWT coefficients; selecting a plurality of the IWT coefficients for incorporation of information therein; and setting signs for the plurality of selected IWT coefficients according to bit values of a plurality of respective data bits. The system and method can also include subjecting a marked pixel domain image to an Integer Wavelet Transform to obtain a matrix of wavelet coefficients; selecting a plurality of the coefficients from the matrix that contain embedded information; and for each selected coefficient, extracting the data bit embedded in the coefficient, a bit value of the extracted data bit determined based on a sign of the coefficient.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.